5-Amino-1MQ guide & protocols

5-Amino-1MQ has a problem no other compound on this site has, and it's worth understanding before you read a single number. Two dosing conventions circulate for it, they sit roughly a hundredfold apart, and both are stated confidently by sources that never mention the other exists. One belongs to a capsule you swallow. The other belongs to a vial you reconstitute. Applying the capsule number to a vial would mean using the whole vial in a day, and it is the single most expensive mistake available on this page.

Vial size isn't part of what follows, since the amount of bacteriostatic water you add sets your concentration either way. Our reconstitution calculator handles that math for whatever vial and target amount you're working with.

What it is

5-Amino-1MQ isn't a peptide, despite being sold beside them everywhere. It's a small synthetic molecule, far smaller than even a short peptide chain, and it works by blocking an enzyme rather than by signalling a receptor. That distinction matters more than it sounds, because it means none of the usual peptide intuitions apply to it, including how it's stored and how it behaves taken by mouth.

The enzyme it blocks is concentrated in white fat tissue and the liver, and it's more active in bodies carrying more fat. Left alone, it consumes cellular resources that fat cells need to run their metabolism efficiently, including the raw material behind NAD+. Blocking it is meant to hand those resources back. That's the whole idea, and it's a genuinely different approach from anything else in this category, which either signals appetite or signals fat release directly.

What people use it for

Metabolism, mostly, and specifically the sense that it has slowed down and stopped responding to the things that used to work. That's a very common experience in midlife and it's what draws most people to this compound. The appeal is that it isn't an appetite suppressant, so it doesn't ask you to eat less, it's aimed at what the fat cells themselves are doing.

The second thread is muscle, and it's the more interesting one. The research that got attention wasn't about fat at all, it was about whether blocking this enzyme could wake up the repair cells in aged muscle that have gone quiet. People running it alongside strength training are usually there for that reason rather than the metabolic one. Both threads come from animal work, and no human research has been published for either.

Formulations

This is where the confusion starts, so it's worth being precise. 5-Amino-1MQ is sold in two entirely different formats. Capsules, swallowed, usually sold as a bottle of many doses. And lyophilized powder in a vial, reconstituted with bacteriostatic water and injected, which is what the research vendors we track sell almost exclusively. Across those vendors, 50 mg vials dominate by a wide margin, with 10 mg the next most common.

Those two formats carry different amounts, different costs per day, and different dosing conventions, and almost nothing written about this compound tells you which one it's talking about. A 50 mg figure means one capsule from a bottle of sixty, or an entire vial. The word is the same. The quantity is not comparable.

Dosing protocols

There is no approved product and no human research establishing any amount, so everything below is convention. What makes this compound unusual is that there are two conventions rather than one, and the table separates them.

See the 5-Amino-1MQ research notes for the underlying research.

Injected patterns above are subcutaneous, with sites commonly rotated because a mild sting is frequently reported.

The arithmetic that settles it

Two of the published figures can be checked against each other, and one of them doesn't survive. Several sources state a 150 to 500 mcg daily injected amount and, often in the same breath, that a 50 mg vial lasts 10 to 20 days. Work it: 50 mg is 50,000 mcg, and at 500 mcg a day that's 100 days, not 20. At 150 mcg a day it's 333 days, close to a year. For a 50 mg vial to run out in 10 to 20 days, the daily amount has to be 2.5 to 5 mg, which is roughly ten times the higher published figure and thirty times the lower one.

So the vial-duration claim and the microgram claim describe different protocols and got copied onto the same page. We can't tell you which is right, because no research settles it. What we can tell you is that they contradict each other, that whoever wrote them didn't check, and that this is the calibre of source underneath a compound people are injecting daily.

Amount total, for planning your purchase: at the 2.5 to 5 mg injected range, a 50 mg vial covers 10 to 20 days, and an 8-week stretch runs 140 to 280 mg, so three to six vials. The oral convention is a different economy entirely: 50 mg a day across 12 weeks is 4,200 mg, which is eighty-four of those 50 mg vials, and nobody is buying research vials to do that. If a source hands you an oral number, it's assuming a capsule product with a completely different cost structure.

How much to reconstitute at once: 50 mg into 2 mL of bacteriostatic water gives 25 mg per mL, so a 2.5 mg amount is 2.5 divided by 25, times 100, which is 10 units on a standard U-100 insulin syringe. The 28-day refrigerated window covers a 50 mg vial comfortably at that rate. Worth noting for anyone reading the microgram figures: a 500 mcg amount at that same concentration is 2 units, which is about as small a draw as an insulin syringe can measure with any accuracy, and a 150 mcg amount is well below it. See how much to reconstitute at once for the general math.

Cycling guidelines

Eight to twelve weeks on with a break after is the pattern described most often, and shorter four-to-six-week runs with a two-to-four-week break also circulate. Neither has anything behind it. The reasoning offered is that the enzyme this compound blocks does other work in the body besides the metabolic job we're interested in, so indefinite suppression is treated as unwise on principle rather than because harm was observed.

That principle is worth taking more seriously here than on most pages. This compound blocks an enzyme rather than nudging a receptor, and enzyme blockade is a blunter intervention with more downstream reach. The absence of long-run data isn't reassuring, it's just absence.

Signs a course is commonly stopped or reconsidered:

• Injection site stinging or irritation that doesn't settle, which is the most frequently reported complaint with the injected form
• Nausea or stomach upset, which is more commonly reported with the oral form
• Headaches or sleep disruption
• Eight to twelve weeks with no change, which is worth naming given that everything here rests on animal work

Stacking

Most commonly paired stack: 5-Amino-1MQ with NAD+ or an NAD+ precursor.

Rationale: the two approach the same shortage from opposite ends. NAD+ supplementation adds more of the raw material; 5-Amino-1MQ is meant to stop an enzyme from consuming it. The argument is that topping up a leaking tank works better if you also slow the leak.

Protocol as run: both dosed daily, usually in the morning, on their own separate schedules rather than combined. NAD+ is commonly run in defined blocks with breaks, so the two schedules often don't line up neatly, and people generally run each on its own pattern rather than forcing them together.

Lighter stacks: MOTS-c comes up as a mitochondrial pairing, on the reasoning that all three are working somewhere in cellular energy production rather than on appetite or hormones. The GLP-1 compounds come up too, and that pairing makes a certain sense on paper, since one works on appetite and the other on what fat cells do, so they're not competing. Neither has combination data.

Combinations to approach carefully: nothing specific is flagged, which as elsewhere on this page reflects how little has been studied rather than a clean record.

Expected results timeline

Early weeks: energy is what people report first, when they report anything, usually within the first two or three weeks. It's self-reported and it's the sort of effect that's hard to separate from having started doing something deliberate about your health.

Months in: body composition changes are described over an eight-to-twelve-week stretch, and they're consistently described as gradual rather than dramatic. Nobody claims this works like a GLP-1, and the people selling it don't either.

Extended, continued use: no data. The animal work ran weeks.

What to expect realistically: the compound comes from essentially one research group, working in mice, and the results have not been independently replicated at any scale. That's a narrower foundation than almost anything else on this site, and it's the honest frame for expectations. The muscle findings in aged animals were striking enough to be genuinely interesting, and they were still findings in mice.

Administration technique

1. The lyophilized powder is reconstituted with bacteriostatic water, added slowly down the inside wall of the vial rather than onto the powder, which reduces foaming.
2. The solution is swirled gently to dissolve rather than shaken. It generally dissolves within a minute.
3. The vial is commonly labelled with the reconstitution date and the resulting concentration, which matters more here than usual given how easily this compound's amounts get confused.
4. The calculated volume is drawn into an insulin syringe.
5. A subcutaneous site is chosen, commonly the abdomen, outer thigh or back of the upper arm, with sites rotated daily because a mild sting is frequently reported.
6. The skin is pinched and the injection given at roughly a 45-degree angle.
7. Where the oral form is used instead, it's commonly taken in the morning, and the injected amounts on this page do not apply to it.

Side effects and safety

Common: stinging at the injection site is the standout, reported often enough that vendors mention it themselves. Nausea and mild stomach upset come up more with the oral form. Headaches are reported with both.

Less common: sleep disruption and a jittery feeling are described occasionally, usually where the amount is toward the top of whichever range is being followed.

What we don't know: nearly everything, and this compound deserves the strongest version of that statement on the site. No human research has been published at all. The enzyme being blocked does other work in the body, including in the liver and in processes not related to fat, and what sustained blockade does over months in a person has never been examined. The market has settled on amounts that are not derived from anything.

Contraindications: pregnancy, breastfeeding and use in minors, on the general principle that applies when there is no data at all. Liver conditions are worth a specific mention, since the liver is one of the two tissues where this enzyme is concentrated.

Drug interactions: none established, because none have been studied. Given that the enzyme involved handles a methylation process the body uses widely, that absence is more notable here than for a compound with a narrow receptor target.

5-Amino-1MQ vs. NAD+

NAD+ is the natural comparison, since the two are aimed at the same cellular shortage from opposite directions, and they're the two compounds people most often weigh against each other in this corner of the market.

Choose 5-Amino-1MQ if: the metabolic and fat-tissue angle is specifically what you're after, and you're comfortable with a compound whose entire case rests on animal work from one laboratory.

Choose NAD+ if: you want the broader and better-established option, with more independent work behind it and a wider set of reasons people run it.

Stacking the two: this is the most commonly described pairing for either compound, on the leaking-tank logic above. See the full comparison for the head-to-head, and the NAD+ guide and protocols for its own dosing.

Storage and handling

Lyophilized powder: being a small molecule rather than a peptide, this one is genuinely more robust than most things on this site and is commonly described as stable at room temperature for a period. Refrigerated and protected from moisture and light is still the safer default, and lot-specific stability should come from the vendor's certificate of analysis.

Reconstituted solution: refrigerate and use within about 28 days, the standard window for a bacteriostatic-water solution. At the injected amounts described here a 50 mg vial fits inside that window comfortably.

Capsules: a sealed container at room temperature, which is one of the few practical advantages the oral form has.

Signs of degradation:

• Cloudiness or visible particles in a solution that was previously clear
• Discoloration of the powder or the reconstituted liquid
• Powder that has clumped or gone sticky, which usually means moisture reached it

FAQ

Is it actually a peptide? No. It's a small synthetic molecule that gets sold alongside peptides, which is why the usual peptide rules about storage and oral use don't apply to it.

Why do the dosing numbers differ so much? Because two markets exist. The capsule market's convention is 50 to 150 mg daily; the research-vial convention is a small fraction of that. Sources rarely say which they mean.

Which number applies to a 50 mg vial? The injected one. Treating a vial like a capsule dose would use the entire vial in a day.

Is the microgram figure wrong? We can't say it's wrong, only that it can't be squared with the vial-duration claim published alongside it, and that at that amount the draw is smaller than an insulin syringe measures reliably.

Has any of this been tested in people? No. Not at any amount, by any route.

How long do people run it? Eight to twelve weeks with a break after is the common pattern, with shorter four-to-six-week runs also described.

Does it suppress appetite? It isn't meant to, and it isn't described that way. It's aimed at what fat cells do rather than at how much you eat.

Can it be stacked with NAD+? That's the most commonly described pairing, on the reasoning that one adds the raw material and the other slows what consumes it.

Bottom line

Key dosing takeaways:

• Two conventions circulate, roughly a hundredfold apart, and which applies depends entirely on whether you bought capsules or a vial
• For the 50 mg vials our vendors sell, 2.5 to 5 mg daily is the injected convention, and it's the figure consistent with the widely repeated 10-to-20-day vial claim
• The published microgram figures cannot be reconciled with that vial-duration claim, and at that size the draw falls below what an insulin syringe measures reliably

Best practices:

• Checking which format a source means before trusting any number it gives you, since almost none of them say
• Labelling the vial with the date and concentration at reconstitution, which matters here more than for any other compound on the site
• Running a defined stretch with a decision point at the end, rather than continuing indefinitely on a compound nobody has studied in a person

Works best for people who:

• Want a metabolic approach that doesn't work through appetite
• Are interested in the aged-muscle angle and understand it's a finding in mice
• Can hold that the mechanism is genuinely interesting and the evidence base is the thinnest on this site

5-Amino-1MQ is sold for research, and no human research on it has been published at all. You already know that. You're an adult making an informed call about your own body, and that's yours to make.